Skip to content

Study on the Efficacy and Safety of Sanqi Renshen Taohong Decoction in Improving Oligomenorrhea and Deficiency of Both Qi and Blood

Study on the Efficacy and Safety of Sanqi Renshen Taohong Decoction in Improving Oligomenorrhea and Deficiency of Both Qi and Blood

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001347
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-05-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scanty menstrual flow

Interventions

Test group:Sanqi Renshen Taohong Yin: twice daily, one bottle each time, for a duration of two menstrual cycles.

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Female volunteers aged 18 to 45 years. 2. Patients with menstrual disorders characterized by basically normal menstrual cycles but significantly reduced menstrual blood loss (more than 50% reduction), or even scanty bleeding, or shortened menstrual duration of less than 2 days with scanty flow, persisting for at least 2 consecutive menstrual cycles. 3. Those meeting the TCM diagnosis of Qi and Blood Deficiency Syndrome (in accordance with the diagnostic criteria for Qi and Blood Deficiency Syndrome in *Guiding Principles for Clinical Research of New Chinese Medicines*). 4. Volunteers with normal liver and renal function. 5. Those who have given informed consent and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with menstrual disorders caused by organic lesions of reproductive organs such as uterine fibroids; 2. Patients with severe primary diseases involving cardiovascular, hepatic, renal and hematopoietic systems; 3. Individuals allergic to any ingredient of the test product; 4. Women who are preparing for pregnancy, pregnant or lactating, as well as those with allergic constitution; 5. Patients with mental illnesses (such as depression, anxiety disorder) or cognitive dysfunction; 6. Individuals with alcohol abuse, heavy smoking (=10 cigarettes per day), or extremely irregular daily routines (e.g., staying up late after 23:00 daily for =5 days per week); 7. Individuals who have taken medications or health foods that may affect the trial results within the past 1 month; 8. Individuals who have participated in other clinical trials within the past 3 months; 9.Individuals deemed inappropriate by the investigator to participate in the clinical trial or unable to complete the study for other reasons.

Design outcomes

Primary

MeasureTime frame
Pictorial Blood Loss Assessment Chart (PBAC);Traditional Chinese Medicine Syndrome Score Scale;Improvement rate of total menstrual blood weight during menstruation; Traditional Chinese Medicine Syndrome Score for Qi Deficiency and Blood Deficiency;

Secondary

MeasureTime frame
Estradiol;Luteinizing Hormone;Follicle-Stimulating Hormone;

Countries

China

Contacts

Public ContactYangyang

The Second Affiliated Hospital of Anhui Medical University

iamyy1208333@163.com139 6503 2103

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026